Cite
APA Citation
Baik, C., Lee, S., Cook, K., Wallace, S., Wood, R., Santana-Davila, R., Chow, L., Rodriguez, C., Eaton, K. D., & Martins, R. (2021). a Phase II study of nab-Paclitaxel (nab-P) in patients with advanced non-small cell lung cancer with EGFR mutations after frontline tyrosine kinase inhibitor therapy. Cancer treatment and research communications, , . http://access.bl.uk/ark:/81055/vdc_100139920787.0x000002